ùÛìí ÃÖ°íÀÇ À¯¹æ¾Ï Àü¹®°¡µéÀÌ ÇÑ ÀÚ¸®¿¡ ¸ð¿©, À¯¹æ¾Ï Ä¡·á¿¡ ´ëÇÑ ÃÖ½ÅÁö°ßÀ» °øÀ¯ÇÏ´Â ÀÚ¸®°¡ 1¿ù 17ÀÏ, 18ÀÏ ¾çÀÏ°£, ¼¿ï´ëÇб³º´¿ø¿¡¼ ¸¶·ÃµÆ´Ù.
À̹ø ¼¼¹Ì³ª´Â ¼¿ï´ëÇб³º´¿ø°ú ±³Åä´ëÇб³º´¿ø ÀÇ·áÁøÀÌ 1³â¿¡ 2ȸ¾¿ ¾çÃø º´¿øÀ» ¹æ¹®ÇØ Çмú±³·ù¸¦ Çϱâ·Î Çù¾àÀ» ¸ÎÀº ÈÄ, 2013³â ù ¹æ¹®¿¡ ÀÌÀº µÎ ¹ø° ¹æ¹®Çà»ç·Î À̹ø Çà»ç¿¡ ±³Åä´ëÇб³º´¿ø ¹æ¹®´ÜÀº ÀÇ»ç »Ó ¾Æ´Ï¶ó, °£È£»ç, ¿¬±¸¿ø µî ´Ù¾çÇÑ Á÷Á¾ÀÇ Á÷¿øµéÀÌ ´ë°Å Âü¿©Çß´Ù.
17ÀÏ(±Ý), ¹æ¹®´ÜÀº ¼¿ï´ëº´¿ø º»°ü °Ç¹°, À¯¹æ °©»ó¼±¼¾ÅÍ ¿Ü·¡ ¹× º°°ü º´µ¿, ÀÇÇйڹ°°ü, ¾Ïº´¿øÀ» µÑ·¯º¸´Â ½Ã°£À» °¡Á³´Ù.
18ÀÏ(Åä)¿¡´Â ¾Ïº´¿ø 2Ãþ ¼¼ºÈ¯È¦¿¡¼ ‘¼¿ï-±³Åä À¯¹æ¾Ï ±³À° ¼¼¹Ì³ª(SEOUL-KYOYO BREAST CANCER EDUCATION SEMINAR)’¸¦ °¡Á³´Ù.
¼¼¹Ì³ª¿¡¼´Â ¡ã Whole exome and transcriptome sequencing of 120 primary breast cancer to discover novel therapeutic target(¿Ü°ú ÇÑ¿ø½Ä ±³¼ö) ¡ãBreast density as a biomarker for endocrine therapy(¿Ü°ú ±èÁö¼± ±³¼ö) ¡ã Cancer stem cell, breast cancer PDX model and biomarker discovery(¿Ü°ú ¹®Çü°ï ±³¼ö) ¡ã Management of axilla in breast cancer patients(»ï¼º¼¿ïº´¿ø ¿Ü°ú ÀÌÁ¤¾ð ±³¼ö) ¡ã Breast MRI: SNUH Experience(¿µ»óÀÇÇаú ¹®¿ì°æ ±³¼ö) ¡ã Endocrine therapy for young breast cancer patients(¿øÀÚ·Â º´¿ø ¿Ü°ú ±èÀº±Ô ±³¼ö) ¡ã Optimal dosing of selective estrogen receptor modulators for breast cancer patients(±³Åä´ëº´¿ø Hiroshi Ishiguro) °¡ ¹ßÇ¥µÆ´Ù.
Âü¼®ÀÚµéÀº ¾ç ±â°üÀÇ ÀÓ»ó ÇöÀå¿¡¼ ÀÖ¾ú´ø ´Ù¾çÇÑ Áõ·Ê¿Í ½ÇÁ¦ Áø·á ³»¿ë¿¡ ´ëÇØ Åä·ÐÇÏ´Â ½Ã°£µµ °¡Á³´Ù.
³ëµ¿¿µ ¼¿ï´ëÇб³¾Ïº´¿øÀåÀº “À̹ø Çà»ç¸¦ ÅëÇØ ¾ç ±â°üÀÌ ´õ¿í ±ä¹ÐÇÑ ÇùÁ¶¿Í Åä·ÐÀ» ÅëÇØ È¯Àڵ鿡°Ô ´õ ³ªÀº Áø·á¸¦ Á¦°øÇÏ°í ¶Ù¾î³ Çмú °á°ú¸¦ ¾òÀ» ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëÇÑ´Ù” °í ¸»Çß´Ù.